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Background: Many pathologies seen in the preterm population are associated with abnormal blood supply, yet
robust evaluation of preterm cardiac function is scarce and consequently normative ranges in this population are
limited. The aim of this study was to quantify and validate left ventricular dimension and function in preterm
infants using cardiovascular magnetic resonance (CMR). An initial investigation of the impact of the common
congenital defect patent ductus arteriosus (PDA) was then carried out.
Methods: Steady State Free Procession short axis stacks were acquired. Normative ranges of left ventricular end
diastolic volume (EDV), stroke volume (SV), left ventricular output (LVO), ejection fraction (EF), left ventricular (LV)
mass, wall thickness and fractional thickening were determined in “healthy” (control) neonates. Left ventricular
parameters were then investigated in PDA infants. Unpaired student t-tests compared the 2 groups. Multiple linear
regression analysis assessed impact of shunt volume in PDA infants, p-value ≤ 0.05 being significant.
Results: 29 control infants median (range) corrected gestational age at scan 34+6(31+1-39+3) weeks were scanned.
EDV, SV, LVO, LV mass normalized by weight and EF were shown to decrease with increasing corrected gestational
age (cGA) in controls. In 16 PDA infants (cGA 30+3(27+3-36+1) weeks) left ventricular dimension and output were
significantly increased, yet there was no significant difference in ejection fraction and fractional thickening between
the two groups. A significant association between shunt volume and increased left ventricular mass correcting for
postnatal age and corrected gestational age existed.
Conclusion: CMR assessment of left ventricular function has been validated in neonates, providing more robust
normative ranges of left ventricular dimension and function in this population. Initial investigation of PDA infants
would suggest that function is relatively maintained.
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Figure 1 Comparison of a 4 chamber and short axis view at end
diastole in a 1.4 kg control infant (left) and 1.4 kg PDA (right)
infant with a shunt volume of 62% of LVO. Apex-base and mid
cavity diameter measurements have been included for scale. Figure
shows the apparent increase in left ventricular dimensions.
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Rates of premature births are increasing in absolute
number and as a percentage of all births [1]. Many path-
ologies seen in this population are associated with
abnormal or inadequate blood supply, yet robust assess-
ment of the preterm cardiovascular system is limited.
The transition from intra- to extra-uterine life requires
abrupt changes in the cardiovascular system to maintain
adequate systemic and pulmonary blood flow in the two
extreme environments. The immature preterm cardio-
vascular system has undergone this transformation when
it is not structurally equipped to do so, these circulatory
changes are often delayed in this cohort [2,3]. It is
thought that this delay in circulatory adaption, the im-
mature preterm cardiovascular system and the resulting
haemodynamics correlate to the presence and develop-
ment of the pathologies seen in this population [3-6].
A common congenital defect in preterm infants clinic-
ally apparent in 60% of infants born less than 28 weeks
gestation is a patent ductus arteriosus (PDA) [3]. It is
common clinical belief that large ductal shunt volumes
increase cardiac workload and are associated with con-
gestive heart failure [2,4,7]; large shunt volumes are
thought to lead to systemic hypo-perfusion and pulmon-
ary hyper-perfusion due to cardiocirculatory dysfunction
[8-10]. It has previously been shown that ductal shunt
volume can range between 8-74% of left ventricular out-
put (LVO) and that LVO is significantly increased in
PDA infants [11,12]. From observation in our previous
study [12], infants with PDA appeared to have enlarged
myocardium and larger ventricular cavity volumes than
the “healthy” control preterm infants (Figure 1), yet the
extent of dilatation and impact of shunt volume and in-
creased work load on cardiac function has not been
quantified and remains unclear.
Echocardiography is currently used to carry out neo-
natal cardiac assessment. Several echocardiography stud-
ies have shown an increase in left ventricular cavity
dimension and stroke volume in PDA infants [11,13],
but have been limited by the accuracy of echocardiog-
raphy to quantify intra cardiac cavity dimensions and
flow volumes [14,15]; measurements have been flawed
by significant observer variability and poor agreement to
reference methods [16]. Furthermore none of these stud-
ies have been able to associate cardiac function with
ductal shunt volume and resultant systemic flow. Conse-
quently robust normative ranges in the preterm popula-
tion are scarce.
Balanced steady state free precession (SSFP) has be-
come a prominent diagnostic and functional tool in
cardiovascular magnetic resonance (CMR), due to the
excellent blood-myocardium contrast from the inherent
T2/T1 weighted contrast and very high signal to noise
efficiency [17]. CMR provides accurate and reproduciblecardiac dimension, function [18] and LVO measures in
adults [19,20] and in cardiac failure patients [21]. A previ-
ous preliminary study demonstrated that functional as-
sessment with CMR in neonates was feasible [22],
however images were acquired without the use of special-
ist receive coils, such that image resolution was limited.
The aim of this study was to firstly quantify and valid-
ate left ventricular (LV) dimension and function parame-
ters in preterm infants using an optimized SSFP stack
sequences [23]. Secondly, to establish normative ranges
in the preterm and term population. Thirdly, to carry
out a preliminary observational study to investigate the
impact of PDA on LV dimension and function.
Methods
The study was approved by the North West London Re-
search Ethics Committee (06/Q0406/137) and written
informed parental consent was obtained in all cases. All
echo and CMR scans were carried out for research pur-
poses only.
Study cohort
CMR was performed on 45 infants who were inpatients
at St Thomas’ and Queen Charlotte’s and Chelsea Hospi-
tals. All infants had an echo performed within 24 hours
of the CMR scan by an operator with >10 years of ex-
perience (AMG) in neonatal echocardiography. Due to
the lack of consensus on optimal PDA management,
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clinical team rather than the significance of the duct
[24]. The Queen Charlotte’s and Chelsea Hospital neo-
natal unit has adopted an approach of non-intervention
for the PDA, leaving the duct to close naturally in most
cases; providing the opportunity to study the duct at a
point in its natural history. All echocardiographic images
were acquired using a Vivid 7 ultrasound machine (GE
Healthcare, Milwaukee, WI) with a 10 MHz sector probe.
Colour Doppler echo assessment was used to determine
the absence or presence of a PDA. PDA shunt volumes
were determined by phase contrast (PC) CMR analysis
[12]. Of these 45 infants, 1 was born a term infant.
Twenty nine neonates (controls) median (range) gesta-
tional age (GA) at birth 33+2(25+5 – 39+1) weeks, cor-
rected GA at scan (cGA) 34+6(31+1-39+3) weeks, birth
weight (BW) 1820(695 – 3045) grams and current weight
at scan (CW) 1880(790 – 3045) grams had closure of the
ductus arteriosus confirmed by echo. Sixteen infants had
PDA determined by echo, median (range) GA 26+5(24+3 –
34) weeks, cGA 30+2(27+3 – 36+1) weeks, BW 955(525 –
2000) grams and CW 1130(660 – 2400) grams.
PDA was treated in 2 infants, both with Ibuprofen 2
days and 59 days prior to the scan. Both were still patent
at the time of the CMR scan. None of the PDA infants
subsequently underwent surgery to close the duct. All of
the 16 PDA infants survived and there were no inci-
dences of necrotising enterocolitis in this cohort. No in-
fant included in this study went on to receive further
treatment for prolonged ductal patency.
CMR acquisition
All infants were scanned using acoustic ear protection,
pulse oximetry, vector ECG monitoring and without sed-
ation or anesthesia, as described previously in Merchant
et al. [25]. Axillary temperature was monitored through-
out the scan for all individuals and remained stable in all
cases. Images were acquired free breathing, as previously
demonstrated the nature of neonatal respiration is pre-
dominately shallow but rapid, minimizing the bulk motion
of the heart within the chest cavity [23]. Seventeen infants
required low flow supplemental oxygen or nasal continu-
ous positive airway pressure via an MR compatible system,
but all infants were stable and tolerating full enteral feeds
during the scan. None of the infants were mechanically
ventilated during the scan.
Due to the high heart rates, lack of patient cooperation
and subject size performing successful CMR in the neo-
natal population requires a tailored approach. Therefore
scanner and parameter optimization fully described in
Price et al. [23] were utilized in this study. This study
showed good agreement between LVO and SV measures
from stack and PC CMR data [23]. Data was acquired on
a Philips 3-Tesla MR Achieva scanner (Best, Netherlands)using a specialised 8 channel pediatric body receive coil
for infants > 2 kg and an 8 channel small extremity receive
coil for infants < 2 kg.
LVO was quantified in all but 6 infants due to patient
unrest from PC CMR. PDA shunt volume was indirectly
calculated from 3 PC sequences quantifying LVO, upper
and lower body flow acquired during the same CMR
scan (acquired in-plane resolution = 0.6 × 0.6 mm, slice
thickness = 4 mm, TR/TE = 5.9/3.1 ms, velocity encoding
ranged from ±60-150 cms−1 depending on slice pos-
ition), full details of the PC CMR sequences are given in
Broadhouse et al. [12]. Ductal shunt volume was calcu-
lated in all but 3 PDA infants as these infants became
unsettled.
A gated 2D SSFP short axis 10 slice stack optimized
for neonatal CMR [23] (acquired in-plane resolution =
1 × 1 mm, slice thickness = 4 mm, TR/TE = 3.8/1.9 ms,
flip angle = 35°) was placed over the heart, aligned with
the mitral valve using previously acquired pilot scans.
Negative slice gap was adjusted for individual infants so
that full coverage from apex to base of the left ventricle
was achieved. Number of signal averages (NSA) ranged
between 2 and 8 depending on size and stability of the
infant. No acceleration methods were used in this study;
acquisition time ranged between 2 and 8 minutes.
Data processing
Quantification of LVO and ductal shunt volume from PC
sequences [12] was performed using a commercial work-
station (Philips ViewForum). Automated vessel edge de-
tection was used for all vessels of interest, with manual
correction where necessary. Stacks were segmented and
LV function quantified using freely available software Seg-
ment v1.8 R1172 (http://segment.heiberg.se) [26]. Myocar-
dial borders were defined by performing a detailed manual
tracing of the epi and endocardium. Long axis motion
(LAC) was corrected for by measuring the mitral valve
displacement on a 4 chamber sequence between the end
diastolic (ED) and end systolic (ES) time points taking an
average of three measures.
Myocardial and ventricular cavity volumes were deter-
mined by summing the area of each slice over the length
for ED and ES time points, the two volumes were then
averaged. Myocardial mass was calculated by multiplying
the left ventricular myocardial volume by 1.05 g/ml [27].
Myocardial wall thickness and fractional thickening as-
sessment was carried out using the 6 mid cavity sections
as defined by the 17 sector American Heart Association
model [28]. Papillary muscles and trabeculae were ex-
cluded from the blood pool area for evaluation of the
blood volume used to calculate end diastolic volume
(EDV), stroke volume (SV), LVO, and ejection fraction
(EF). Papillary muscles and trabeculae were included in
the blood pool volume for calculation of the myocardial
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left ventricular (LV) mass.
Statistical analysis
Intra- and inter-observer variability analysis of EDV,
ESV, SV, LVO, EF, LV mass and LAC was carried out in
10 infants picked at random from the control cohort.
Bland-Altman analysis was used to assess agreement
between the 2 measures. Mean difference of measures,
limits of agreement (LOA) and repeatability index (LOA/
mean of measures, RI) were also calculated.
The LV output measures LVO, SV, EF and ventricular
dimensions EDV and LV mass normalized by weight at
scan (as is convention in the neonatal population) were
plotted against corrected gestational age to visually as-
sess the impact of PDA on LV measures. EDV was plot-
ted against SV to investigate the relationship between
filling and stroke volume in control and PDA infants to
look for evidence of alteration in the Frank Starling
curve [29]. LV mass was plotted against EF to investigate
the relationship between the apparent enlarged left ven-
tricle and cardiac function in PDA infants.
La Place’s law states a linear relationship between ven-
tricular diameter and wall stress. Therefore to maintain
cardiac function, any scenario producing increased left
ventricular diameter would be expected to also produce
a proportional increase in myocardial thickness. To
examine whether any increase in LVmass in infants with
PDA is proportionate or disproportionate to extent of
LV blood volume change, the ratio between LV myocar-
dial volume and LV blood pool volume at end diastole
(LVmass/EDV, where in this case LVmass is = LVmass/
1.05 g/ml, the volume of myocardium) was examined.
An unpaired Student’s t-test compared EDV, SV, LVO,
EF, LVmass, ED wall thickness, fractional thickening,
and LVmass/EDV ratio in infants with and without
PDA. Linear regressions were carried out in control in-
fants to determine association between EF and the ven-
tricular measures: LVmass and EDV. It was recognised
that by the nature of PDA the PDA and control infants
were different cohorts with respect to GA, cGA andTable 1 Bland-Altman intra- and inter-observer analysis for ED
Intra-observer
Mean diff % RI % LOA
EDV ml 3.6 7.1 −0.2 – 0
ESV ml 9.2 13.6 −0.1 – 0
SV ml/min 1.6 8.7 −0.3 – 0
LVO ml/min 1.8 8.9 −38.3 –
EF % −1.9 4.2 −4.6 – 1
LVmass g 9.2 13.9 −0.1 – 0
LAC mm −3.4 12.7 −0.9 – 0postnatal age. Consequently multiple linear regressions
were carried out in solely PDA infants to determine as-
sociation between LV mass, EDV and LVmass/EDV ratio
with ductal shunt volume in these infants correcting for
cGA and postnatal age. Association between EF and
LVmass, EDV and ductal shunt volume was also investi-
gated in the PDA infants.
To assess whether differences in LVmass could be
related primarily to illness severity rather than PDA
shunting, the association between number of days on re-
spiratory support from birth to discharge and LVmass
correcting for cGA, postnatal age and ductal patency
was investigated. Statistical significance was determined
by a p value < 0.05.
Results
10 control infants with median (range) GA 33+2(26+2 –
35+4) weeks, cGA 35+2(32+1 – 37+3) weeks, BW 1860
(1040 – 2770) grams and CW 1980(1060 – 2770) grams
were assessed for intra- and inter-observer variability
analysis. Bland-Altman intra- and inter-observer vari-
ability analysis for the LV dimension and functional
parameters showed good agreement between all LV di-
mension and functional parameters, RI ranged between
4.2 – 13.9% for intra-observer variability and 6.6 - 23.1%
for inter-observer variability (Table 1). Mean and range
of LV volume and function parameters from control in-
fants are shown in Table 2. Normative ranges (Figure 2a,
b, c, d, e and f ) show a decrease in EDV, SV, LVO, LV
mass (normalized by weight at scan) and EF with in-
creasing cGA.
Of the 16 PDA infants (13 assessed by PC CMR), the
median (range) ductal shunt volume was 26(3.4-74.2)%
of LVO and 86.0(17.0 – 434.8) ml/kg/min. Table 3 shows
ductal shunt volume as a % of LVO and in ml/kg/min
for all 13 infants. Unpaired Student’s t-tests showed that
EDV, SV, LVO, ED wall thickness, LVmass and LVmass/
EDV are significantly increased in PDA infants. There
was no significant difference between EF and fractional
thickening in both groups (Table 4). For visual analysis
EDV, SV, LVO, LVmass (normalized by weight at scan),V, ESV, SV, LVO, EF, LVmass and LAC in 10 control infants
Inter-observer
Mean diff % RI % LOA
.5 −0.5 11.6 −0.4 – 0.6
.3 8.3 19.0 −0.1 – 0.4
.4 −3.5 12.7 −0.6 – 0.4
56.9 −3.6 12.5 −87.7 – 48.8
.7 −3.2 6.6 −7.3 – 2.5
.7 18.1 16.2 0.1 – 1.0
.5 −11.11 23.1 −2.2 – 1.0
Table 2 Mean and range of LVO, SV, EDV, LVmass
(normalized by weight at scan), EF and HR in control infants
Mean Range
LVO ml/kg/min 260 137 - 360
SV ml/kg 1.83 1.31 - 2.29
EDV ml/kg 2.47 1.73 - 2.29
LVmass g/kg 1.39 0.85 - 1.91
EF % 74 68 - 81
HR bpm 141 101 - 176
Figure 2 Normative ranges with trend line and 95% confidence limits
ventricular output (LVO), d: left ventricular (LV) mass, e: heart rate (H
(+) PDA.
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e and f). Seven of the 16 PDA infants have EDV, SV and
LVO above the population 95% confidence limits. One
PDA infant has EDV and SV below the population 95%
confidence limits. LVmass is dramatically increased in
PDA infants with all but 5 above the population 95%
confidence limits. Heart rate in all PDA infants remained
within the population 95% confidence limits. Mean
(range) EF was found to be 74(68 – 81)% in control in-
fants. All but 3 infants had an EF within or above theof a: end diastolic volume (EDV), b: stroke volume (SV), c: left
R) and f: ejection fraction (EF) in 45 infants with (●) and without
Table 3 Ductal shunt volumes: GA, cGA, birth weight (BW), weight (Wt) at scan and corresponding ductal shunt values
as determined by PC CMR for 13 infants with PDA
GA weeks Cga weeks BW kg CW kg Shunt volume % LVO Shunt volume
ml/kg/min
24+3 27+3 0.53 0.66 74.2 435
26+3 28+3 0.95 0.95 66.5 336
28+4 31+4 1.40 1.43 62.0 359
25+4 31+6 0.68 1.13 52.7 275
26+1 30+1 0.99 1.08 51.6 221
27 29+2 1.14 1.14 48.7 169
27 29+1 1.18 1.18 26.0 86
26+2 36+1 0.91 2.40 23.5 72
25+5 27+5 0.81 0.81 15.5 45
25+3 30+4 0.85 0.88 15.0 58
27 29+1 0.89 0.89 13.5 46
27+2 31+6 0.90 1.22 12.1 39
31+3 32+1 1.39 1.39 3.4 17
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found to be 75(63 – 89)%. All PDA infants had EF above
the threshold of >50% for normal EF in adults [30] and
had mean EF above the mean EF of 69% found in
healthy pediatric subjects aged between 8–12 years [31].
Plotting a population Frank Starling curve (EDV
against SV) revealed a linear trend irrespective of ductal
patency (Figure 3a). All but 2 PDA infants had EF within
or above the 95% confidence limits when plotted against
LV mass (Figure 3b).
The ratio of LVmass/EDV is approximately constant
with increasing EDV in control infants. An inverse rela-
tionship is observed in the PDA infants where LVmass/
EDV decreases with increased EDV and with 7 of the
PDA infants above the 95% confidence limits. Figure 4
highlights the inverse relationship between EDV and
LVmass/EDV ratio.Table 4 t-test analysis of left ventricular output, function
and hypertrophic measures showing mean and p-values
for control and PDA groups
T-tests
Mean controls Mean PDA p value
LVO ml/kg/min 260(56) 432(127) <0.001
SV ml/kg 1.82(0.29) 2.81(0.83) <0.001
EDV ml/kg 2.47(0.38) 3.83(1.34) 0.001
LV mass g/kg 1.39(0.23) 2.46(0.59) <0.001
ED Myo thickness mm/kg 1.07 2.07 <0.001
LVmass/EDV 0.54(0.08) 0.68(0.17) 0.02
EF % 74(4) 75(8) 0.80
Fractional Thickening % 77 80 0.69Linear regression analysis showed that there was no sig-
nificant relationship between EF and EDV or LVmass in
control infants. In PDA infants there was no significant
association between EF and ductal shunt volume or LV
mass, however a significant inverse relationship was found
between EF and EDV (p = 0.02).
Multiple linear regression analysis showed a significant
positive association between LV mass and ductal shunt
volume, and between EDV and ductal shunt volume
both persisted when correcting for cGA and postnatal
age in multiple linear regression (both with p < 0.01). A
significant inverse relationship between LVmass/EDV
and ductal shunt volume persisted when correcting for
both cGA and postnatal age (p < 0.01). No significant as-
sociation between number of days on respiratory sup-
port and LV mass correcting for cGA, postnatal age and
ductal shunt volume was found.
Discussion
The preterm cardiovascular system, the cardiac function
and the associated pathologies are poorly understood.
Although functional CMR is well established in adult
and pediatric populations the translation to the neonatal
cohort has been challenging due to the nature of the
subjects. This and the limitations in echocardiography
have meant that robust neonatal normative ranges are
scarce. The recent application of CMR in neonates
[12,22,23] has made it possible to evaluate cardiac di-
mension and function in this cohort. In this study volu-
metric and functional CMR assessments with the
optimized acquisitions [23] have been quantified and
validated. Preterm normative ranges of left ventricular
dimension and function were determined and utilized
for a preliminary investigation of the impact of PDA.
Figure 3 Analysis of left ventricular mass. a: Population Frank Starling curve and b: left ventricular (LV) mass plotted against ejection fraction
(EF) for infants with (●) and without (+) PDA.
Broadhouse et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:54 Page 7 of 9
http://jcmr-online.com/content/16/1/54Bland-Altman analysis of intra- and inter-observer
variability indicates good agreement between EDV, SV,
LVO and EF measures (RI ranged between 4.2 -12.8%,
Table 1). Intra- and inter-observer LV mass and ESV
measures showed reasonable agreement (RI = 13.6, 13.0
and 19.0, 16.2% respectively). This reduced repeatability
in ESV is due to the variability in LAC measures (RI =
12.7 and 23.1%). Post processing software corrected for
long axis motion in integer values. This is not problem-
atic in adults but can be significant in infants with basal
to apex lengths of ~ 25 mm. An increment of 1 mm
could lead to an alteration in EF of 2% and therefore
even larger difference in ESV. These repeatability mea-
sures were a marked improvement over echo values
[14–16] and are comparable to pediatric CMR studies
[31]. Robbers-Visser et al. [31] found a coefficient of
variance ranging from 2.1 – 13.9% for intra- and inter-
observer variability, this would imply an RI of 4.1 –
27.2% (intra- and inter-observer variability RI range =
4.2 – 23% in this study).Figure 4 Normative range of the myocardial volume to end
diastolic volume (LVmass/EDV) ratio against EDV in infants with
(●) and without (+) PDA. The relationship between increased
LVmass/EDV ratio and decreased EDV is illustrated.The quantitative measures (EDV, SV, LVO, LVmass
and HR) showed a linear decrease with increasing cGA
(Figure 2a, b, c, d, and e). For the range of cGA of this
cohort the increase in weight is predominantly attrib-
uted to an increase in adipose tissue which requires pro-
portionally less blood flow than organs, hence a decrease
in LV output and dimension when normalized by weight
at scan is expected with increasing cGA. EF remained
relatively constant across cGA with a mean (range) EF
of 74(68 – 81)%. For comparison a previous CMR study
assessing normal biventricular function, volumes and
mass in a pediatric cohort (8-12 yrs) showed an average
EF of 69% [31]. Linear regression analysis also showed
no significant relationship between EF and GA, cGA,
EDV or LV mass in control infants, indicating that these
infant’s hearts are well within their comfortable func-
tioning range.
Visual assessment from normative ranges and un-
paired t-tests showed that in PDA infants EDV was sig-
nificantly increased, suggesting volume loading on the
heart. In addition SV, LVO and LVmass were increased,
indicating that these hearts are experiencing an in-
creased workload. Despite the widely held clinical belief
that PDA presents with increased HR, a sign of distress
in neonates, even in the presence of large ductal shunt
volumes (up to 74% of LVO) PDA infants had HR con-
sistently within the normal range. This indicated that
LVO was increased in PDA infants primarily by in-
creased SV due to a larger EDV than increase in HR.
Despite the increase in LV volume loading and workload
there was no significant difference in EF between control
and PDA infants. The data in this study supports the
idea that an individualized treatment approach is needed
and may suggest that not all large shunt volumes lead to
heart failure.
This preliminary data presented here may suggest an
overall maintenance of contractile function in PDA
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the threshold defining normal EF, (>50%) mean (range)
75(63 – 89)% [30] and were within range of pediatric
data (mean EF = 69%) [29]. From the Frank Starling
curve all PDA infants appear to remain on the same lin-
ear trend as control infants; there is no evidence of a
drop in stroke volume with very large EDV. Indicating
that in general the Frank Starling mechanism adequately
compensates for the mechanical disadvantage imposed
by Laplace's law (the linear relationship between ven-
tricular diameter and wall stress) in these enlarged
hearts. While a significant inverse relationship was found
between EF and EDV (p = 0.006) in PDA infants, all but 3
infants had EF within or above the normal range.
While contractile function seems to be generally main-
tained in PDA infants there is clearly a significant in-
crease in LVmass. This increase is not explained by
differences in cGA and postnatal age. Assessment of the
correlation between ductal shunt volume and this enlarge-
ment was investigated by considering the relationship be-
tween EDV and the ratio of LVmass/EDV. This ratio was
almost constant in control infants. The LVmass/EDV was
higher overall in PDA infants. However, there was a sig-
nificant association between increased LVmass/EDV and
decreased ductal shunt volume in PDA infants. Indicating
that infants with lower shunt volumes may have hyper-
trophic growth which is more disproportionate than in-
fants with high shunt volumes.
This relationship appears counter intuitive and warrants
examination in a larger cohort of infants. However, lower
ductal shunt volumes could be indicative of high pulmon-
ary vascular resistance, which could lead to increased right
ventricular afterload and subsequently lead to overall in-
creased myocardial mass in the lower shunt volume infants.
Although, there was no significant association between
number of days on respiratory support from birth to dis-
charge and LVmass correcting for cGA, postnatal age and
ductal shunt volume, this could be due to the small number
of infants and the number of confounding factors.
Study limitations
This study has three significant limitations. Firstly due
to the nature of PDA (increased incidence that is in-
versely related to gestational age) there was a significant
difference in cGA between control and PDA infants:
there are relatively few infants <30 week cGA without a
PDA in this study. Graphic comparison between control
and PDA infants was performed by linear extrapolation
of the 95% confidence limits, it is feasible that infants
<30 weeks cGA without a PDA do not follow this linear
trend. The significant differences from t-test analysis in
LV volumetric data between the control and PDA groups
could be due to the difference in GA, cGA and postnatal
age of the 2 groups and not the presence of a PDA. Theresultant impact of the immature circulatory system are
numerous, complex and poorly understood as both the
body tissues and the circulation and heart supplying
them are immature. Many studies are now suggesting
that the association between pathologies and PDA could
be casual rather than causal and this may also be the
case with the LV volumetric data presented in this study.
Secondly a relatively small number of PDA infants
were studied at a time of clinical stability and outside
the transitional period. We have presented data suggest-
ing that cardiac function is maintained even in infants
with a high ductal shunt volume. However, it may be
that at other points, during a time of clinical instability
and particularly in the first few days of life during the
circulatory transition where dramatic changes occur in
preload conditions, myocardial contractility and systemic
and pulmonary vascular resistance in PDA infants may
not be within this regime.
Thirdly we have presented data at only one time point;
we have no temporal data of the ductal shunt volume
and resultant cardiac status. The duration of the heart’s
transition to adapt to the increased volume load or
whether this enlargement persists long after the closure
of the duct is unknown. Although there was no signifi-
cant association between EF and shunt volume the ven-
tricular dimensions were significantly increased, whether
this increase in LV mass is due to hypertrophy or hyper-
plasia is difficult to determine and if this is evidence of
pathological ventricular remodeling is unclear.
Conclusions
In summary, this study presents data validating CMR as-
sessment of LV volumes and function in preterm and term
infants, a cohort in which data is scarce. Normative ranges
were established in this population and then utilized to in-
vestigate left ventricular dimension and function in the
presence of a PDA. LVO, EDV and LV mass were found to
be significantly increased in PDA infants. Moreover a sig-
nificant association was found between increased LV mass
and ductal shunt volume. A significant increase in LVmass/
EDV was found in PDA infants suggesting that these hearts
may be disproportionately hypertrophic. However, EF and
fractional thickening remained within the normal range
and no association was found between EF and ductal shunt
volume. In addition, none of the PDA infants appear be-
yond the peak of the Frank Starling curve. This may suggest
that function is generally maintained in these enlarged
hearts. The data highlights the fact that more study is
needed to aid individual treatment approach.
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